What is the role of the metabolic activity of the gut microbiota in inflammatory bowel disease? probing for answers with stable isotopes

Journal of Pediatric Gastroenterology and Nutrition

Volumn 46, Issue 5, 2008, Pages 486-495

  Barclay, Andrew R ^a,c   Morrison, Douglas J ^b   Weaver, Lawrence T ^a  

^a UNIVERSITY OF GLASGOW   (United Kingdom)

^b SCOTTISH UNIVERSITIES ENVIRONMENTAL RESEARCH CENTRE   (United Kingdom)

^c ROYAL HOSPITAL FOR SICK CHILDREN   (United Kingdom)

Author keywords

16S rRNA; Gut microbiota pathogenesis; Inflammatory bowel disease; Stable isotope probing

Indexed keywords

BACTERIAL DNA; BACTERIAL RNA; BUTYRIC ACID; CASPASE RECRUITMENT DOMAIN PROTEIN 15; GAMMA INTERFERON; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 1; INTERLEUKIN 12; INTERLEUKIN 23; INTERLEUKIN 6; INTERLEUKIN 8; PROBIOTIC AGENT; RNA 16S; STABLE ISOTOPE; TUMOR NECROSIS FACTOR ALPHA;

BACTERIAL METABOLISM; BACTERIODES VULGATES; BACTERIUM; BIFIDOBACTERIUM; CLOSTRIDIUM DIFFICILE; CLOSTRIDIUM LEPTUM; COLITIS; CROHN DISEASE; ENTERITIS; ESCHERICHIA COLI; EUBACTERIUM; HOST; HUMAN; IMMUNE SYSTEM; IMMUNOPATHOLOGY; IN VIVO STUDY; INFLAMMATION; INTESTINE FLORA; ISOTOPE LABELING; LIQUID CHROMATOGRAPHY; MASS SPECTROMETRY; METABOLOME; MICROBIAL ACTIVITY; MICROBIAL DIVERSITY; MUTATION; NONHUMAN; OLIGONUCLEOTIDE PROBE; PATHOGENESIS; PHYLOGENY; PRIORITY JOURNAL; REVIEW; ULCERATIVE COLITIS; CHEMISTRY; GENETIC PREDISPOSITION; GENETICS; IMMUNOLOGY; INTESTINE MUCOSA; ISOLATION AND PURIFICATION; MICROBIOLOGY; SPECIES DIFFERENCE;

BACTERIA (MICROORGANISMS);

BACTERIA; DNA, BACTERIAL; GENETIC PREDISPOSITION TO DISEASE; HUMANS; INFLAMMATORY BOWEL DISEASES; INTESTINAL MUCOSA; ISOTOPE LABELING; RNA, BACTERIAL; SPECIES SPECIFICITY;

EID: 48249156638     PISSN: 02772116     EISSN: None     Source Type: Journal    
DOI: 10.1097/MPG.0b013e3181615b3a     Document Type: Review

References (99)

1. Armitage E, Drummond HE, Wilson DC, et al. Increasing incidence of both juvenile-onset Crohn's disease and ulcerative colitis in Scotland. Eur J Gastroenterol Hepatol 2001;13:1439-47.
2. Sawczenko A, Sandhu BK, Logan RF, et al. Prospective survey of childhood inflammatory bowel disease in the British Isles. Lancet 2001;357:1093-4.
3. Strachan DP. Hay fever, hygiene, and household size. BMJ 1989;299:1259-60.
4. H2 lymphocytes: their role in the pathophysiology of atopy. Allergy 1992;47:450-5.
5. H2 diseases coexist? Evaluation of asthma incidence in children with coeliac disease, type 1 diabetes, or rheumatoid arthritis: a register study. J Allergy Clin Immunol 2001;108:781-3.
6. Stene LC, Nafstad P. Relation between occurrence of type 1 diabetes and asthma. Lancet 2001;357:607-8.
7. Onkamo P, Vaananen S, Karvonen M, et al. Worldwide increase in incidence of Type I diabetes-the analysis of the data on published incidence trends. Diabetologia 1999;42:1395-403.
8. Ravikumara M, Tuthill DP, Jenkins HR. The changing clinical presentation of coeliac disease. Arch Dis Child 2006;91:969-71.
9. Moayyedi P. Invited commentary: clues to the etiology of inflammatory bowel disease-a return to John Snow? Am J Epidemiol 2006;164:624-6.
10. Bouma G, Strober W. The immunological and genetic basis of inflammatory bowel disease. Nat Rev Immunol 2003;3:521-33.
11. Yuan Q, Walker WA. Innate immunity of the gut: mucosal defense in health and disease. J Pediatr Gastroenterol Nutr 2004;38:463-73.
12. Sartor RB. Role of commensal enteric bacteria in the pathogenesis of immune-mediated intestinal inflammation: lessons from animal models and implications for translational research. J Pediatr Gastroenterol Nutr 2005;40 (Suppl 1):S30-1.
13. Gaya DR, Russell RK, Nimmo ER, et al. New genes in inflammatory bowel disease: lessons for complex diseases? Lancet 2006;367:1271-84.
14. Hugot JP, Chamaillard M, Zouali H, et al. Association of NOD2 leucine-rich repeat variants with susceptibility to Crohn's disease. Nature 2001;411:599-603.
15. Ogura Y, Bonen DK, Inohara N, et al. A frameshift mutation in NOD2 associated with susceptibility to Crohn's disease. Nature 2001;411:603-6.
16. Inohara N, Ogura Y, Fontalba A, et al. Host recognition of bacterial muramyl dipeptide mediated through NOD2. Implications for Crohn's disease. J Biol Chem 2003;278:5509-12.
17. Van Limbergen J, Russell RK, Nimmo ER, et al. The genetics of inflammatory bowel disease. Am J Gastroenterol 2007; 102:2820-31.
18. Brynskov J, Nielsen OH, Ahnfelt-Ronne I, et al. Cytokines (immunoinflammatory hormones) and their natural regulation in inflammatory bowel disease (Crohn's disease and ulcerative colitis): a review. Dig Dis 1994;12:290-304.
19. Hooper LV, Wong MH, Thelin A, et al. Molecular analysis of commensal host-microbial relationships in the intestine. Science 2001;291:881-4.
20. McGovern D, Powrie F. The IL23 axis plays a key role in the pathogenesis of IBD. Gut 2007;56:1333-6.
21. Targan SR, Hanauer SB, van Deventer SJ, et al. A short-term study of chimeric monoclonal antibody cA2 to tumor necrosis factor α for Crohn's disease. Crohn's Disease cA2 Study Group. N Engl J Med 1997;337:1029-35.
22. Ahn DH, Crawley SC, Hokari R, et al. TNF-α activates MUC2 transcription via NF-KBbut inhibits via JNK activation. Cell Physiol Biochem 2005;15:29-40.
23. Barnes PJ, Karin M. Nuclear factor- KB : a pivotal transcription factor in chronic inflammatory diseases. N Engl J Med 1997;336:1066-71.
24. Boone DL, Lee EG, Libby S, et al. Recent advances in understanding NF-KB regulation. Inflamm Bowel Dis 2002;8: 201-12.
25. Schreiber S. The complicated path to true causes of disease: role of nuclear factor KB in inflammatory bowel disease. Gut 2005;54: 444-5.
26. Moreau MC. Influence of the intestinal microflora on host immunity: normal physiological conditions. In: Rambaud JC, Buts JP, Corthier G (eds). Gut Microflora: Digestive Physiology and Pathology. et al. Paris: John Libbey Eurotext; 2006. pp. 131 -49.
27. Guarner F, Malagelada JR. Gut flora in health and disease. Lancet 2003;361:512-9.
28. Zoetendal EG, Akkermans AD, de Vos WM. Temperature gradient gel electrophoresis analysis of 16S rRNA from human fecal samples reveals stable and host-specific communities of active bacteria. Appl Environ Microbiol 1998;64:3854-9.
29. Wilson KH, Perini F Role of competition for nutrients in suppression of Clostridium difficile by the colonic microflora. Infect Immun 1988;56:2610-4.
30. Silva M, Jacobus NV, Deneke C, et al. Antimicrobial substance from a human Lactobacillus strain. Antimicrob Agents Chemother 1987;31:1231-3.
31. Golder JP, Doe WF Isolation and preliminary characterization of human intestinal macrophages. Gastroenterology 1983;84:795-802.
32. Bilsborough J, Viney JL. Gastrointestinal dendritic cells play a role in immunity, tolerance, and disease. Gastroenterology 2004;127: 300-9.
33. Otte JM, Rosenberg IM, Podolsky DK. Intestinal myofibroblasts in innate immune responses of the intestine. Gastroenterology 2003; 124:1866-78.
34. Macpherson AJ, Harris NL. Interactions between commensal intestinal bacteria and the immune system. Nat Rev Immunol 2004;4: 478-85.
35. Weng Q, Walker WA. Bacterial colonization, probiotics, and clinical disease. J Pediatr 2006;149 (Suppl 1):S107-14.
36. Umesaki Y, Setoyama H. Structure of the intestinal flora responsible for development of the gut immune system in a rodent model. Microbes Infect 2000;2:1343-51.
37. Kraus TA, Mayer L. Oral tolerance and inflammatory bowel disease. Curr Opin Gastroenterol 2005;21:692-6.
38. Macpherson AJ, Uhr T. Induction of protective IgA by intestinal dendritic cells carrying commensal bacteria. Science 2004;303: 1662-5.
39. Rowland IR. Interactions of the gut microflora and the host in toxicology. Toxicol Pathol 1988;16:147-53.
40. Cummings JH, Macfarlane GT. Role of intestinal bacteria in nutrient metabolism. J Parenter Enteral Nutr 1997;21:357-65.
41. Christian MT, Edwards CA, Preston T, et al. Starch fermentation by faecal bacteria of infants, toddlers, and adults: importance for energy salvage. Eur J Clin Nutr 2003;57:1486-91.
42. Gassull MA. Review article: the intestinal lumen as a therapeutic target in inflammatory bowel disease. Aliment Pharmacol Ther 2006;24 (Suppl 3):90-5.
43. Mueller C, Macpherson AJ. Layers of mutualism with commensal bacteria protect us from intestinal inflammation. Gut 2006;55:276-84.
44. Sartor RB. The influence of normal microbial flora on the development of chronic mucosal inflammation. Res Immunol 1997;148: 567-76.
45. Sellon RK, Tonkonogy S, Schultz M, et al. Resident enteric bacteria are necessary for development of spontaneous colitis and immune system activation in interleukin-10-deficient mice. Infect Immun 1998;66:5224-31.
46. Rutgeerts P, Goboes K, Peeters M, et al. Effect of faecal stream diversion on recurrence of Crohn's disease in the neoterminal ileum. Lancet 1991;338:771-4.
47. Sechi LA, Ahmed N, Felis GE, et al. Immunogenicity and cytoad-herence of recombinant heparin binding haemagglutinin (HBHA) of Mycobacterium avium subsp. paratuberculosis: functional promiscuity or a role in virulence? Vaccine 2006;24:236-43.
48. Chacon O, Bermudez LE, Barletta RG. Johne's disease, inflammatory bowel disease, and Mycobacterium paratuberculosis. Annu Rev Microbiol 2004;58:329-63.
49. Korzenik JR. Past and current theories of etiology of IBD: toothpaste, worms, and refrigerators. J Clin Gastroenterol 2005;39 (Suppl 2):S59-65.
50. Marteau P, Lepage P, Mangin I, et al. Review article: gut flora and inflammatory bowel disease. Aliment Pharmacol Ther 2004;20 (Suppl 4):18-23.
51. Tamboli CP, Neut C, Desreumaux P, et al. Dysbiosis in inflammatory bowel disease. Gut 2004;53:1-4.
52. Resta-Lenert S, Barrett KE. Probiotics and commensals reverse TNF-a- and IFN-7-induced dysfunction in human intestinal epithelial cells. Gastroenterology 2006;130:731-46.
53. Meyer AM, Ramzan NN, Loftus EV Jr et al. The diagnostic yield of stool pathogen studies during relapses of inflammatory bowel disease. J Clin Gastroenterol 2004;38:772-5.
54. Manichanh C, Rigottier-Gois L, Bonnaud E, et al. Reduced diversity of faecal microbiota in Crohn's disease revealed by a metagenomic approach. Gut 2006;55:205-11.
55. Favier C, Neut C, Mizon C, et al. Fecal beta-D-galactosidase production and Bifidobacteria are decreased in Crohn's disease. Dig Dis Sci 1997;42:817-22.
56. Mangin I, Bonnet R, Steak P, et al. Molecular inventory of faecal microflora in patients with Crohn's disease. FEMS Microbiol Ecol 2004;50:25-36.
57. Ott SJ, Musfeldt M, Wenderoth DF, et al. Reduction in diversity of the colonic mucosa associated bacterial microflora in patients with active inflammatory bowel disease. Gut 2004;53: 685-93.
58. Lionetti P, Callegari ML, Ferrari S, et al. Enteral nutrition and microflora in pediatric Crohn's disease. J Parenter Enteral Nutr 2005;29 (Suppl 4):S173-5.
59. Seksik P, Rigottier-Gois L, Gramet G, et al. Alterations of the dominant faecal bacterial groups in patients with Crohn's disease of the colon. Gut 2003;52:237-42.
60. Segain JP, de la Bletiere DR, Bourreille A, et al. Butyrate inhibits inflammatory responses through NFKB inhibition: implications for Crohn's disease. Gut 2000;47:397-403.
61. Sanderson IR. Short chain fatty acid regulation of signaling genes expressed by the intestinal epithelium. J Nutr 2004; 134: 2450S-4.
62. Wong JM, de Souza R, Kendall CW, et al. Colonic health: fermentation and short chain fatty acids. J Clin Gastroenterol 2006; 40:235-43.
63. Scheppach W, Weiler F The butyrate story: old wine in new bottles? Curr Opin Clin Nutr Metab Care 2004;7:563-7.
64. Van Nuenen MH, Venema K, van der Woude JC, et al. The metabolic activity of fecal microbiota from healthy individuals and patients with inflammatory bowel disease. Dig Dis Sci 2004; 49:485-91.
65. Scheppach W, Sommer H, Kirchner T, et al. Effect of butyrate enemas on the colonic mucosa in distal ulcerative colitis. Gastroenterology 1992;103:51-6.
66. Di Sabatino A, Morera R, Ciccocioppo R, et al. Oral butyrate for mildly to moderately active Crohn's disease. Aliment Pharmacol Ther 2005;22:789-94.
67. Macfarlane S, Furrie E, Kennedy A, et al. Mucosal bacteria in ulcerative colitis. Br J Nutr 2005;93 (Suppl l):S67-72.
68. Rodriguez-Valera F Environmental genomics, the big picture? FEMS Microbiol Lett 2004;231:153-8.
69. Blaut M, Collins MD, Welling GW, et al. Molecular biological methods for studying the gut microbiota: the EU human gut flora project. Br J Nutr 2002;87 (Suppl 2):S203-11.
70. Eckburg PB, Bik EM, Bernstein CN, et al. Diversity of the human intestinal microbial flora. Science 2005;308:1635-8.
71. Woodmansey EJ, McMurdo ME, Macfarlane GT, et al. Comparison of compositions and metabolic activities of fecal microbiotas in young adults and in antibiotic-treated and non-antibiotic-treated elderly subjects. Appl Environ Microbiol 2004;70:6113-22.
72. Pitcher MC, Beatty ER, Cummings JH. The contribution of sulphate reducing bacteria and 5-aminosalicylic acid to faecal sulphide in patients with ulcerative colitis. Gut 2000; 46:64-72.
73. Macfarlane S, Macfarlane GT. Composition and metabolic activities of bacterial biofilms colonizing food residues in the human gut. Appl Environ Microbiol 2006;72:6204-11.
74. Parrett AM, Edwards CA. In vitro fermentation of carbohydrate by breast fed and formula fed infants. Arch Dis Child 1997;76:249-53.
75. Adamczyk J, Hesselsoe M, Iversen N, et al. The isotope array, a new tool that employs substrate-mediated labeling of rRNA for determination of microbial community structure and function. Appl Environ Microbiol 2003;69:6875-87.
76. Ouverney CC, Fuhrman JA. Combined microautoradiography- 16S rRNA probe technique for determination of radioisotope uptake by specific microbial cell types in situ. Appl Environ Microbiol 1999;65:1746-52.
77. Wagner M, Nielsen PH, Loy A, et al. Linking microbial community structure with function: fluorescence in situ hybridization-microautoradiography and isotope arrays. Curr Opin Biotechnol 2006;17:83-91.
78. Nielsen JL, Aquino de Muro M, Nielsen PH. Evaluation of the redox dye 5-cyano-2, 3-tolyl-tetrazolium chloride for activity studies by simultaneous use of microautoradiography and fluorescence in situ hybridization. Appl Environ Microbiol 2003;69:641-3.
79. Dumont MG, Murrell JC. Stable isotope probing-linking microbial identity to function. Nat Rev Microbiol 2005;3:499-504.
80. Friedrich MW. Stable-isotope probing of DNA: insights into the function of uncultivated microorganisms from isotopically labeled metagenomes. Curr Opin Biotechnol 2006;17:59-66.
81. Meselson M, Stahl FW. The replication of DNA in Escherichia coli. Proc Natl Acad Sci USA 1958;44:671-82.
82. Ling SC, Amarri S, Slater C, et al. Liver disease does not affect lipolysis as measured with the 13C-mixed triacylglycerol breath test in children with cystic fibrosis. J Pediatr Gastroenterol Nutr 2000;30:368-72.
83. Amarri S, Harding M, Coward WA, et al. 13C and H2 breath tests to study extent and site of starch digestion in children with cystic fibrosis. J Pediatr Gastroenterol Nutr 1999;29:327-31.
84. Christian MT, Amarri S, Franchini F, et al. Modeling 13C breath curves to determine site and extent of starch digestion and fermentation in infants. J Pediatr Gastroenterol Nutr 2002;34:158-64.
85. Morrison DJ, Dodson B, Preston T, et al. Gastrointestinal handling of glycosyl [13C]ureides. Eur J Clin Nutr 2003;57:1017-24.
86. Morrison DJ, Cooper K, Waldron S, et al. A streamlined approach to the analysis of volatile fatty acids and its application to the measurement of whole-body flux. Rapid Commun Mass Spectrom 2004;18:2593-600.
87. Morrison DJ, Mackay WG, Edwards CA, et al. Butyrate production from oligofructose fermentation by the human faecal flora: what is the contribution of extracellular acetate and lactate? Br J Nutr 2006;96:570-7.
88. McDonald IR, Radajewski S, Murrell JC. Stable isotope probing of nucleic acids in methanotrophs and methylotrophs: a review. Org Geochem 2006;36:779-87.
89. Lueders T, Wagner B, Claus P, et al. Stable isotope probing of rRNA and DNA reveals a dynamic methylotroph community and trophic interactions with fungi and protozoa in oxic rice field soil. Environ Microbiol 2004;6:60-72.
90. Zoetendal EG, Cheng B, Koike S, et al. Molecular microbial ecology of the gastrointestinal tract: from phylogeny to function. Curr Issues Intest Microbiol 2004;5:31-47.
91. Manefield M, Whiteley AS, Ostle N, et al. Technical considerations for RNA-based stable isotope probing: an approach to associating microbial diversity with microbial community function. Rapid Commun Mass Spectrom 2002;16:2179-83.
92. Radajewski S, McDonald IR, Murrell JC. Stable-isotope probing of nucleic acids: a window to the function of uncultured microorganisms. Curr Opin Biotechnol 2003;14:296-302.
93. Neufeld JD, Dumont MG, Vohra J, et al. Methodological considerations for the use of stable isotope probing in microbial ecology. Microb Ecol 2006;53:435-42.
94. Belenguer A, Duncan SH, Calder AG, et al. Two routes of metabolic cross-feeding between Bifidobacterium adolescentis and butyrate-producing anaerobes from the human gut. Appl Environ Microbiol 2006;72:3593-9.
95. Falony G, Vlachou A, Verbrugghe K, et al. Cross-feeding between Bifidobacterium longum BB536 and acetate-converting, butyrate-producing colon bacteria during growth on oligofructose. Appl Environ Microbiol 2006;72:7835-41.
96. Egert M, de Graaf AA, Maathuis A, et al. Identification of glucose-fermenting bacteria present in an in vitro model of the human intestine by RNA-stable isotope probing. FEMS Microbiol Ecol 2007;60:126-35.
97. Gibson GR, Macfarlane GT. Human Colonic Bacteria: Role in Nutrition, Physiology, and Pathophysiology Boca Raton, FL: CRC Press; 1995.
98. Mackay WG, Williams CL, McMillan M, et al. Evaluation of protocol using gene capture and PCR for detection of Helicobacter pylori DNA in feces. J Clin Microbiol 2003;41:4589-93.
99. MacGregor BJ, Bruchert V, Fleischer S, et al. Isolation of small-subunit rRNA for stable isotopic characterization. Environ Microbiol 2002;4:451-64. 100. Pearson A, Sessions AL, Edwards KJ, et al. Phylogenetically specific separation of rRNA from prokaryotes for isotopic analysis. Mar Chem 2006;92:295-306.